Increased expression of TBC1 domain family member 16 (TBC1D16), a gene involved in the regulation of cell growth and differentiation, is associated with an increased risk of non-remission and worse overall survival in patients with AML. This evidence concerns the gene TBC1D16 and acute myeloid leukemia.